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AcylationAbstract Schiff base derivatives of benzothiazole 2a–e have been synthesized by reacting with
substituted 2-aminobenzothiazole 1a–e and different substituted benzaldehydes 5a–e. The obtained
Schiff bases reaction with NaBH4 has afforded the corresponding some novel amines 3a–e. The
condensation of amines with chloroacetylchloride leads to novel amide derivatives 4a–e. The struc-
tures of the synthesized compounds are characterized by elemental analysis, IR, MS, 1H NMR and
13C NMR.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Various substituted benzothiazoles are known to cover a large
domain of pharmacological activities serving as antitumor
(Beneteau et al., 1999), anti-microbial (Kabeer et al., 2001;
Hassan et al., 1978), anthelmintic (Nadkarni et al., 2000), anal-
gesic (Mruthyunjayasawmy and Shanthaveerappa, 2000),
anti-inﬂammatory (Pontiki and Hadjipavoulou-Litina, 2007;
Miyamatsu et al., 1974; Bhusari et al., 2001, 2000a,b) and anti-
convulsive (Hays et al., 1994) agents. Moreover, it was reported
that the Schiff bases (Hadjipavlou-Litina and Geronikaki,
1998) of thiazole and benzothiazole act as inhibitors of the
lipoxygenase affecting inﬂammation and/or psoriasis. Lipoxy-
genase is an enzyme which catalyzes the rate-limiting step inthe biosynthesis of leukotrienes from arachidonic acid (Brain
and Williams, 1990; Muller, 1994). The effective role of azome-
thine linkage in some biological reactions was also studied
(Geronikaki, 1990). Similarly, substituted N-benzothiazol-2-
yl-amides are an important class of heterocyclic compounds
that exhibit a wide range of biological properties such as ubiq-
uitin ligase inhibitors (Parlati et al., 2005), antitumor (Yoshida
et al., 2005), antirotavirus infections (Bailey and Pevear, 2004),
the adenosine receptor (Alanine et al., 2001; Kerwin et al.,
1997) and the nuclear hormone receptor (Kerwin et al.,
1997). In particular, some benzothiazoles substituted at the 2-
position with a benzoylamino moiety showed antibacterial,
antifungal and antitubercular activities (Brade et al., 1998)
and it is therefore of interest to consider the synthesis of novel
Schiff bases of benzothiazole and amides except 2b–e and 3d.
The compounds were described in the literature (Rathod
et al., 2000; Li et al., 1998; Subramanian et al., 2009; Ojha
et al., 2001; Shimidzu and Uno, 1973).
In our previous study, some novel benzothiazole Schiff
bases and their reduced amine compounds were determined by
UV–vis spectroscopic technique and their acidity constants
and pKa values were evaluated in structure elucidation and
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(O¨g˘retir et al., 2009). In the present work, we report on (i)
the synthesis of a novel benzothiazole Schiff base (ii) reduction
of the obtained imines (iii) synthesis of the corresponding
amide (iv) spectroscopic characterization of the obtained
compounds.
2. Experimental
Melting points (mp) were determined on Gallenkamp appara-
tus, Infrared (FT-IR) spectra were recorded as pressed KBr
disc, using Perkin Elmer Precisely Spectrum 100 FT-IR Spec-
trophotometer, 1H NMR and 13C NMR spectra were recorded
Bruker DPX FT NMR (500 MHz) and (125 MHz) spectrome-
ter instrument at 298 K. Chemical shifts are given in d (ppm)
relative to TMS (DMSO-d6) as the internal standard. Electron
impact mass spectra (EI) were obtained using a (LS/MS-APCl)
AGILENT 1100 MSD spectrometer at 100 eV. Elemental
analyses were obtained on Elementar Analsensysteme GmbH
varioMICRO CHNS (Turkish Technical and Scientiﬁc
Research Council Laboratories, Ankara, Turkey). TLC was
performed on pre-coated silica gel plates (Merk 60, F254,
0.25 mm). Organic solvents used were of HPLC grade or were
puriﬁed by the standard procedure. All reagents were of com-
mercial quality or were puriﬁed before use.
2.1. General procedure for the synthesis of Schiff’s Bases 2a–e
(Vicini et al., 2003)
A solution of 2-amino-6-methyl benzothiazole (1a, 10 g,
61 mmol) and m-hydroxy benzaldehyde (5a, 7.45 g, 61 mmol)
in methanol (100 ml) was reﬂuxed for 2 h. The mixture was left
to stand at room temperature overnight and then concen-
trated. The residue was washed with n-hexane (2 · 100 ml)
and ﬁltered off. The residue was hydrolyzed in water and ex-
tracted with EtOAc (4 · 50 ml). After drying in Na2SO4 and
evaporation, the crude product (2a, 12.5 g, 76%) was obtained
then recrystallized from CH2Cl2. Compounds 2b–e were pre-
pared using the same method described above.
2.1.1. 3-{[(6-Methyl-1,3-benzothiazol-2-yl)imino]
methyl}phenol 2a
Yield:12.5 g (76%) mp 212–214 C. 1H NMR (DMSO-d6,
500 MHz): d 2.40 (s, 3H, CH3-Benzothiazole), 7.06 (dd,
J= 7.9 Hz, 1H, H13), 7.33 (dd, J= 8.26 Hz, 1H, H15), 7.40
(t, J= 7.84 Hz, 1H, H14), 7.49 (s, 1H, H11), 7.50 (d,
J= 8.56 Hz, 1H, H4), 7.82 (d, J= 8.28 Hz, 1H, H5), 7.84
(s, 1H, H7), 9.10 (s, 1H, –CH‚N–), 9.90 (br s, 1H, Ar-OH).
13C NMR (DMSO-d6 125 MHz): d 21.58, 117.88, 121.53,
122.37, 122.69, 128.54, 130.72, 134.62, 135.53, 136.32, 149.84,
158.35, 167.54, 170.76, 193.59 ppm. MS (EI): m/z
(%) = 269.1 (M++1, 21.5), 271.1 (2.5), 165.0 (100), 137.1
(45). Anal. Calcd for C15H12N2OS: C, 67.14; H, 4.51; N,
10.44; S, 11.95. Found: C, 67.28; H, 4.67; N, 10.52; S, 11,35.
IR mmax 3300, 3045, 3040, 1605, 1597, 1530, 1505 cm
1.
2.1.2. 2-{[(4-Methyl-1,3-benzothiazol-2-yl)imino]
methyl}phenol 2b
Yield: 14.31 g (88%) mp 160–162 C. 1H NMR (DMSO-d6,
500 MHz): d 2.65 (s, 3H, CH3-Benzothiazole), 7.01 (d,
J= 7.42 Hz, 1H, H12), 7.04 (t, J= 8.20 Hz, 1H, H6), 7.31
(d, J= 7.39 Hz, 1H, H5), 7.33 (d, J= 8.77 Hz, 1H, H7),7.52 (dt, J= 8.44 Hz, 1H, H13), 7.87 (t, J= .8.56 Hz, 1H,
H14), 7.94 (dd, J= 7.80 Hz, 1H, H15), 9.4 (s, 1H, –
CH‚N–), 11.80 (br s, 1H, Ar-OH). 13C NMR (DMSO-d6
125 MHz): d 18.55, 117.42, 120.13, 120.19, 120.32, 125.80,
127.58, 131.47, 132.72, 134.07, 136.04, 150.94, 160.94, 166.08,
169.73 ppm. MS (EI): m/z (%) = 269.1 (M++1, 8.7), 241.1
(6.5), 179.1 (5.2), 165.1 (100), 137.1 (6.5). Anal. Calcd for
C15H12N2OS: C, 67.14; H, 4.51; N, 10.44; S, 11.95. Found:
C, 67.04; H, 4.08; N, 10.52; S, 11.46. IR mmax 3373, 1604,
1597, 1551 cm1.
2.1.3. 6-Methyl-N-[(4-methylphenyl)methylidene]-1,3-
benzothiazol-2-amine 2c
Yield: 11.68 g (72%) mp 146–147 C. (DMSO-d6, 500 MHz): d
2.43 (s, 3H, Ar-CH3), 2.46 (s, 3H, CH3-Benzothiazole), 7.34
(dd, J= 7.59 Hz, 1H, H5), 7.42 (d, J= 7.99 Hz, 2H, H12,
H14), 7.82 (d, J= 8.28 Hz, 1H, H4), 7.87 (s, 1H, H7), 8.00
(d, J= 8.07 Hz, 2H, H11, H15), 9.14 (s, 1H, –CH‚N–). 13C
NMR (DMSO-d6 125 MHz); d 21.57, 21.88, 122.36, 122.63,
128.50, 130.30, 130.59, 132.50, 134.59, 135.43, 144.58, 149.85,
167.20, 170.95 ppm. Anal. Calcd for C16H14N2S: C, 72.15;
H, 5.30; N, 10.52; S, 12.04. Found: C, 72.01; H, 5.40; N,
10.36; S, 11.98. IR mmax 1607, 1589, 1556 cm
1.
2.1.4. 2-[(1,3-Benzothiazol-2-ylimino)methyl]phenol 2d
Yield: 13.26 g (85%) mp 149–151 C. 1H NMR (DMSO-d6,
500 MHz): d 6.77 (t, J= 7.35 Hz, 1H, H5), 6.83 (d,
J= 7.93 Hz, 1H, H12), 7.02 (t, J= 7.53 Hz, 1H, H13), 7.1
(t, J= 7.36 Hz, 1H, H14), 7.21 (t, J= 7.19 Hz, 1H, H6),
7.23 (d, J= 7.29 Hz, 1H, H4), 7.38 (d, J= 7.91 Hz, 1H,
H7), 7.66 (d, J= 7.71 Hz, 1H, H15), 9.05 (s, 1H, –CH‚N–
), 11.50 (br s, 1H, OH). 13C NMR (DMSO-d6 125 MHz): d
117.44, 120.09, 120.33, 122.89, 123.07, 125.78, 127.20, 131.54,
134.43, 136.15, 151.70, 161.05, 166.33, 170.91 ppm. MS (EI):
m/z (%) = 255.1 (M++1, 24.2), 209.0 (23.9), 177.0 (23.2),
151.0 (100), 137.1 (11.5). Anal. Calcd for C14H10N2OS: C,
66.12; H, 3.96; N, 11.02; S, 12.61. Found: C, 66.10; H, 3.90;
N, 11.03; S, 12.59. IR mmax 3437, 1609, 1572, 1505 cm
1.
2.1.5. N-[(4-methoxyphenyl)methylidene]-6-methyl-1,3-
benzothiazol-2-amine 2e
Yield: 10.1 g (65%) mp 132–133 C. 1H NMR (DMSO-d6,
500 MHz): d 2.45 (s, 3H, CH3-Benzothiazole), 3.89 (s, 3H,
Ar-OCH3), 7.15 (d, J= 8.85 Hz, 2H, H12, H14), 7.33 (d,
J= 8.55 Hz, 1H, H5), 7.80 (d, J= 8.25 Hz, 1H, H4), 7.84
(s, 1H, H7), 8.06 (d, J= 8.75 Hz, 2H, H11, H15), 9.09 (s,
1H, –CH‚N–). 13C NMR (DMSO-d6 125 MHz): d 21.56,
56.14, 115.23, 122.31, 122.47, 127.84, 128.41, 132.74, 134.45,
135.22, 149.89, 164.12, 166.48, 171.19 ppm. Anal. Calcd for
C16H14N2OS: C, 68.06; H, 5.00; N, 9.92; S, 1136. Found: C,
68.1; H, 4.97; N, 9.98; S, 10.98. IR mmax 1600, 1569, 1466 cm
1.
2.2. General procedure for the synthesis of substituted 1,3-
benzothiazole-2-yl phenyl methyl amine 3a–e (Billman and
Diesing, 1957)
3-{[(6-Methyl-1,3-benzothiazol-2-yl)imino]methyl}phenol (2a,
6 g, 22.3 mmol) were dissolved in methanol NaBH4 was added
to the stirred solution at room temperature until the yellow
color of the Schiff bases disappeared. Cold water was added
to the solution to precipitate the compounds. The precipitates
were recrystallized from methanol to obtain compound 3a
S1316 H.C. Sakarya et al.(5.529 g, 92%). Compounds 3b–e were prepared using the
same method described above.
2.2.1. 3-{[(6-Methyl-1,3-benzothiazol-2-yl)amino]
methyl}phenol 3a
Yield: 5.52 g (92%) mp 169–171 C. 1H NMR (DMSO-d6,
500 MHz): d 2.32 (s, 3H, CH3-benzothiazole), 4.50 (d,
J= 5.60 Hz, 2H, Ar-CH2N), 6.65 (d, J= 7.22 Hz, 1H,
H15), 6.79 (s, 1H, H11, d, J= 6.08 Hz, 1H, H13), 7.02 (d,
J= 8.13 Hz, 1H, H5), 7.14 (t, J= 7.98 Hz, 1H, H14), 7.28
(d, J= 8.12 Hz, 1H, H4), 7.46 (s, 1H, H7), 8.35 (t,
J= 5.62 Hz, 1H, NH-benzothiazole), 9.4 (br s, 1H, Ar-OH).
13C NMR (DMSO-d6 125 MHz): d 21.22, 47.60, 114.40,
114.56, 118.20, 118.36, 121.35, 127.01, 129.80, 130.50, 130.95,
140.93, 150.81, 157.91, 166.04 ppm. MS (EI): m/z
(%) = 272.1 (M++2, 17.9), 271.1 (M++1, 100), 107.1
(11.2). Anal. Calcd for C15H14N2OS: C, 66.64; H, 5.22; N,
10.36; S, 11.86. Found: C, 66.62; H, 5.20; N, 10.34; S, 11.82.
IR mmax 3520, 3412, 1594, 1571 cm
1.
2.2.2. 2-{[(4-Methyl-1,3-benzothiazol-2-yl)amino]
methyl}phenol 3b
Yield: 5.61 g (93%) mp 199–200 C. 1H NMR (DMSO-d6,
500 MHz): d 2.46 (s, 3H, CH3-benzothiazole), 4.52 (d,
J= 5.72 Hz, 2H, Ar-CH2N), 6.79 (dt, J= 7.39 Hz, 1H,
H14), 6.84 (dd, J= 8.06 Hz, 1H, H12), 6.93 (t, J= 7.40 Hz,
1H, H13), 7.06 (d, J= 7.40 Hz, 1H, H15), 7.11 (dt,
J= 7.69 Hz, 1H, H6), 7.27 (dd, J= 7.52 Hz, 1H, H5), 7.47
(d, J= 7.75 Hz, 1H, H7), 8.45 (t, J= 5.79 Hz, 1H, NH-ben-
zothiazole), 10.00 (br s, 1H, Ar-OH). 13C NMR (DMSO-d6
125 MHz): d 18.62 43.32, 116.08, 118.93, 119.42, 121.39,
125.34, 126.83, 127.49, 128.87, 129.90, 130.09, 151.27, 155.71,
166.50 ppm.. MS (EI): m/z (%) = 272.1 (M++2, 11.3),
271.1 (M++1, 73.2), 165.00 (100.0), 107.1 (9.4). Anal. Calcd
for C15H14N2OS: C, 66.64; H, 5.22; N, 10.36; S, 11.86. Found:
C, 66.01; H, 5.02; N, 10.15; S, 11.78. IR mmax 3525, 3430, 1602,
1594 cm1.
2.2.3. 6-Methyl-N-(4-methylbenzyl)-1,3-benzothiazol-2-amine
3c
Yield: 5.01 g (83%) mp 203–204 C. 1H NMR (DMSO-d6,
500 MHz): d 2.20 (s, 3H, Ar-CH3), 2.40 (s, 3H, CH3-benzothi-
azole), 4.51 (d, J= 5.73 Hz, 2H, Ar-CH2N), 7.03 (d,
J= 7.40 Hz, 1H, H5), 7.17 (d, J= 7.80 Hz, 2H, H12, H14),
7.27 (d, J= 8.05 Hz, 3H, H11, H15 and H4), 7.48 (s, 1H,
H7), 8.34 (t, J= 5.72 Hz, 1H, NH-benzothiazole). 13C NMR
(DMSO-d6 125 MHz): d 21.15, 21.22, 47.45, 118.20, 121.34,
127.00, 127.86, 129.37, 130.50, 130.94, 136.42, 136.55, 150.81
165.97 ppm. Anal. Calcd for C16H16N2S: C, 71.60; H, 6.01;
N, 10.44; S, 11.95. Found: C, 71.59; H, 5.99; N, 10.45; S,
11.92. IR mmax 3330, 1602, 1595 cm
1.
2.2.4. 2-[(1,3-Benzothiazol-2-ylamino)methyl]phenol 3d
Yield: 5.56 g (92%) mp 181–182 C. 1H NMR (DMSO-d6,
500 MHz): d 4.51 (s, 2H, Ar-CH2N), 6.77 (t, J= 7.30 Hz,
1H, H5), 6.83 (d, J= 7.93 Hz, 1H, H6), 7.02 (d,
J= 7.53 Hz, 1H, H12), 7.10 (t, J= 7.36 Hz, 1H, H13), 7.21
(t, J= 7.19 Hz, 1H, H14), 7.23 (d, J= 7.29 Hz, 1H, H4),
7.38 (d, J= 7.91 Hz, 1H, H7), 7.66 (d, J= 7.71 Hz, 1H,
H15), 8.40 (s, 1H, NH-benzothiazole). 13C NMR (DMSO-d6
125 MHz): d 43.14, 115.79, 118.34, 119.37, 121.42, 121.44,
125.22, 126,03, 128.69, 129.29, 130.75, 152.64, 155.61,166.92 ppm. MS (EI): m/z (%) = 256.0.(M+, 16), 257.1
(100), 151.0 (80), 107.1 (2.5). Anal. Calcd for C14H12N2OS:
C, 65.60; H, 4.72; N, 10.93; S, 12.51. Found: C, 65.61; H,
4.70; N, 10.95; S, 12.49. IR mmax 3416, 1594, 1571, 1551 cm
1.
2.2.5. N-(4-methoxybenzyl)-6-methyl-1,3-benzothiazol-2-amine
3e
Yield: 4.41 g (73%) mp 175–176 C. 1H NMR (DMSO-d6,
500 MHz): d 2.3 (s, 3H, Ar-CH3), 3.75 (s, 3H, CH3-ben-
zothiazol), 4.50 (d, 2H, J= 5.63 Hz, Ar-CH2), 6.91 (d,
J= 8.64 Hz, 2H, H12, H14), 7.03 (d, J= 8.12 Hz, 1H, H5),
7.27 (d, J= 8.11 Hz, 1H, H4), 7.31 (d, J= 8.60 Hz, 2H,
H11, H15), 7.46 (s, 1H, H7), 8.31 (t, 1H, J= 5.63 Hz, NH-
benzothiazole). 13C NMR (DMSO-d6 125 MHz): d 21.72,
47.19, 55.54, 114.23, 118.19, 121.34, 126.99, 129.27, 130.48,
130.92, 131.34, 150.82, 158.86, 165.92 ppm. Anal. Calcd for
C16H16N2OS: C, 67.58; H, 5.67; N, 9.85; S, 11.28. Found: C,
67.55; H, 5.65; N, 9.83; S, 11.31. IR mmax 3420, 1600,
1570 cm1.
2.3. General procedure for the synthesis of the substituted N-
benzothiazole-2-yl-amides 4a–e (Davion et al., 2004)
To a mixture of the amine compound (3a, 5.00 g, 18.49 mmol)
and triethylamine (1 ml, 7.10 mmol) in dry dichloromethane
(DCM) (50 ml) was added chloroacetyl chloride (4.41 ml,
55.47 mmol). The reaction mixture was heated to reﬂux for
1 h. After cooling, the precipitated product was ﬁltered off.
The crude residue was heated, hydrolyzed in water
(10 ml) and extracted with dichloromethane (5 · 10 ml). After
drying (MgSO4) and evaporation, crystalline was obtained
(4a, 6.3 g, 80%), which was recrystallized from chloroform.
Compounds 4b–e were prepared using the same method
described above.2.3.1. 3-{[(Chloroacetyl)(6-methyl-1,3-benzothiazol-2-
yl)amino]methyl}phenyl chloroacetate 4a
Yield: 6.3 g (80%) mp 157–158 C. 1H NMR (DMSO-d6,
500 MHz): d 2.45 (s, 3H, CH3-benzothiazole), 4.65 (s, 2H,
Ar-CH2N), 4.75 (s, 2H, O(CO)CH2Cl), 5.51 (s, 2H,
N(CO)CH2Cl), 7.10 (s, 1H, H7), 7.12 (d, J= 8.42 Hz, 1H,
H4), 7.21 (d, J= 7.66 Hz, 1H, H13), 7.27 (d, J= 8.27 Hz,
1H, H5), 7.48 (t, J= 7.71 Hz, 1H, H14), 7.68 (d,
J= 8.11 Hz, 1H, H15), 7.83 (s, 1H, H11). MS (EI): m/z
(%) = 423.00 (M+, 7.9), 349.00 (59.3), 347.00 (100), 285.1
(32.1), 107.1 (8.4). Anal. Calcd for C19H16Cl2N2O3S: C,
53.90; H, 3.81; N, 6.62; S, 7.58. Found: C, 53.92; H, 3.80; N,
6.60; S, 7.57. IR mmax 1780, 1672, 1610, 1505 cm
1.2.3.2. 2-{[(Chloroacetyl)(4-methyl-1,3-benzothiazol-2-
yl)amino]methyl}phenyl chloroacetate 4b
Yield: 5.01 g (64%) mp 139–140 C. 1H NMR (DMSO-d6,
500 MHz): d 2.45 (s, 3H, CH3-benzothiazole), 4.73 (s, 2H,
Ar-CH2N), 4.76 (s, 2H, O(CO)CH2Cl), 5.53 (s, 2H,
N(CO)CH2Cl), 7.16 (d, J= 7.66 Hz, 1H, H12), 7.23–7.32
(m, 4H, H13, H14, H5 and H7), 7.39 (br t, J= 7.68 Hz, 1H,
H15), 7.83 (br t, J= 4.26 Hz, 1H, H6). MS (EI): m/z
(%) = 424.00 (M++1, 6.4), 347 (60.9), 241.00 (100.0), 105.1
(3.9). Anal. Calcd for C19H16Cl2N2O3S: C, 53.90; H, 3.81; N,
6.62; S, 7.58. Found: C, 53.90; H, 3.82; N, 6.61; S, 7.57. IR
mmax 1715, 1700, 1624, 1582, cm
1.
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methylbenzyl)acetamide 4c
Yield: 4.5 g (70%) mp 164–165 C. 1H NMR (DMSO-d6,
500 MHz): d 2.27 (s, 3H, Ar-CH3), 2.43 (s, 3H, CH3-benzothi-
azole), 4.75 (s, 2H, Ar-CH2N), 5.55 (s, 2H, N(CO)CH2Cl),
7.14 (d, J= 8.54 Hz, 2H, H12, H14), 7.17 (d, J= 8.52 Hz,
2H, H11, H15), 7.27 (d, J= 8.24 Hz, 1H, H5), 7.66 (d,
J= 8.26 Hz, 1H, H4), 7.83 (br s, 1H, H7). 13C NMR
(DMSO-d6 125 MHz): d 21.10, 21.50, 43.96, 50.16, 121.35,
121.67, 126.59, 128.14, 129.35, 133,30, 133.57, 134.31, 137.15,
145.96, 159,01, 167.72 ppm. MS (EI): m/z (%) = 346.1
(M++1, 17.20), 345.1 (M+, 100), 269.1 (35.00), 105.1
(43.25). Anal. Calcd for C18H17ClN2OS: C, 62.69; H, 4.97;
N, 8.12; S, 9.30. Found: C, 62.67; H, 4.89; N, 8.02; S, 9.23.
IR mmax 1689, 1602, 1505 cm
1.
2.3.4. 2-{[1,3-Benzothiazol-2-
yl(chloroacetyl)amino]methyl}phenyl chloroacetate 4d
Yield: 7.87 g (82%) mp 137–139 C. 1H NMR (DMSO-d6,
500 MHz): d 4.70 (s, 2H, Ar-CH2N), 4.80 (s, 2H,
O(CO)CH2Cl), 5.55 (s, 2H, N(CO)CH2Cl), 7.08 (d,
J= 7.61 Hz, 1H, H12), 7.24 (dt, J= 7.28 Hz, 1H, H6), 7.31
(dd, J= 7.28 Hz, 1H, H4), 7.38 (t, J= 8.47 Hz, 2H, H13
and H14), 7.45 (dt, J= 7.65 Hz 1H, H5), 7.76 (dd,
J= 8.06 Hz, 1H, H7), 8.05 (d, J= 7.66 Hz, 1H, H15). MS
(EI): m/z (%) = 410.0 (M+, 21.9), 409.00 (100.0), 333.0
(3.5), 183.00 (94.1), 107.1 (23.8). Anal. Calcd for
C18H14Cl2N2O3S: C, 52.82; H, 3.45; N, 6.84; S, 7.83. Found:
C, 52.80; H, 3.44; N, 6.80; S, 7.85. IR mmax 1758, 1699, 1611,
1563, 1502 cm1.
2.3.5. 2-Chloro-N-(4-methoxybenzyl)-N-(6-methyl-1,3-
benzothiazol-2-yl)acetamide 4e
Yield: 6.09 g (80%) mp 162–163 C. 1H NMR (DMSO-d6,
500 MHz): d 2.40 (s, 3H, CH3-benzothiazole), 3.70 (s, 3H,
Ar-OCH3), 4.75 (s, 2H, Ar-CH2N), 5.51 (s, 2H,
N(CO)CH2Cl), 6.92 (d, J= 8.59 Hz, 2H, H12, H14), 7.21
(d, J= 8.55 Hz, 2H, H11, H15), 7.28 (d, J= 8.24 Hz, 1H,
H5), 7.68 (d, J= 8.25 Hz, 1H, H4), 7.83 (s, 1H, H7). 13C
NMR (DMSO-d6 125 MHz): d 21.50, 44.00, 49.88, 55.54,
114.70, 121.12, 121.35, 121.59, 121.67, 128.42, 133.30, 134.31,
145.97, 159.10, 167.71 ppm. Anal. Calcd for C18H17ClN2O2S:
C, 59.91; H, 4.75; N, 7.76; S, 8.89. Found: C, 59.83; H, 4.65;
N, 7.75; S, 8.82. IR mmax 1701, 1615, 1582, 1515 cm
1.
3. Results and discussion
The title compounds, 2a–4e have been synthesized according
to the described process in Scheme 1. The structures of all
the compounds 2a–4e were established on the basis of elemen-
tal analyses, IR, 1H NMR, 13C NMR and Mass spectral data.
The novel Schiff base 2a was synthesized according to
Scheme 1. The products 2b and 2e compounds which were
formed through the condensation of aldehyde with amines
and 3d were literature compounds (Rathod et al., 2000; Li
et al., 1998; Subramanian et al., 2009; Ojha et al., 2001 and
Shimidzu and Uno, 1973). Compounds 2a, 2c and 2d were
formed through the condensation of aldehyde with amines in
good yields (76, 72 and 85%). The IR spectra of benzothiazole
Schiff base 2a–e exhibit one characteristic band within the
range of 1605–1615 cm1, which can be assigned as
(–CH‚N–). The existence of the aromatic rings is proved bythe following bands: aromatic carbon-H stretching tC–H
(3045–3040 cm1), phenyl ring stretching tC–C (1597, 1530,
1505 cm1).
In the 1H NMR spectra of benzothiazole Schiff bases, the
chemical shift of the aromatic protons is observed within the
7.01–8.06 ppm region of spectrum. The hydroxyl protons for
2a, 2b and 2d appear as a broad signal within the 9.90–
11.80 ppm. A sharp singlet is observed within the 9.05–
9.14 ppm region of spectrum, which corresponds to the azome-
thine proton.
Furthermore, in the 13C NMR spectrum, a down ﬁeld shift
in peak positions is observed at d 167.54 ppm due to the pres-
ence of carbon atom which is double bonded to nitrogen
atoms. The EI-MS of 2a, 2b and 2d show strong molecular
ion peaks (m/z 269.1, 15.5%), (m/z 269.1, 10.5%), (m/z
254.1, 10%), respectively. This suggests that the reaction of
substituted 2-aminobenzothiazole with different substituted
benzaldehydes produces exclusively the Schiff bases. These
data conﬁrm the proposed stoichiometry and the structure.
The reduction of benzothiazole Schiff bases 2a–e by NaBH4
in methanol afforded the corresponding amine compounds 3a–
e in good yields 73–93% (Scheme 1). IR studies of each amine
compound conﬁrm the formation of –NH– groups, which are
observed in the range of 3350–3437 cm1. The spectra of com-
pounds 3a and 3b having free OH groups display somewhat
broadened bands within the 3420–3425 cm1 region. The inte-
gral intensities of each signal in the 1H NMR spectra of the
amine compounds are found to agree with the number of differ-
ent types of protons present. The 1H NMR spectra of the com-
pounds 3a–e revealed a ﬁne triplet at d 8.31–8.45 ppm for the –
NH– group. The signals of the methylene protons for the –
CH2–NH– group were detected in the region expected in the
range of d 4.50–4.52 ppm as a doublet. The spectra of 3a and
3b show a singlet at d 9.4 and d 10.0 ppm due to the hydrogen
of the hydroxyl group. In the 1H NMR spectra of compound
3a, the peaks at 6.65 ppm (d, 1H), 6.79 ppm (s, d, 2H),
7.02 ppm (d, 1H), 7.14 ppm (t, 1H), 7.28 ppm (d, 1H) and
7.46 ppm (s, 1H) are assigned to be H15, H11, H13, H5, H14,
H4, H17, respectively, as aromatic protons. Aromatic protons
of compounds 3b–e show similar characteristics as those dis-
cussed in compound 3a. In the mass spectral pattern of com-
pound 3a and 3d, the base peak is the M++1 (m/z 271.1,
100%), M++1 (m/z 257.1, 100%), respectively.
The substituted amine compounds 3a–e were reacted with
chloroacetyl chloride in dichloromethane to provide the corre-
sponding amide4c, 4e and esters in good yield 4a, 4b and 4d 60–
80% (Scheme 1). The IR spectra of the ester products depict m(–
N–C‚O) bands within the range of 1672–1699 cm1 and
m(OC‚O) bands at 1715–1780 cm1, which support the as-
signed structure 4a, 4b and 4d. In the IR spectra of the obtained
amides 4c and 4e, carbonyl amide absorption bands appeared
to be at 1689–1701 cm1. Spectral studies reveal that the amide
possesses mono carbonyl group. In the 1H NMR spectra of the
ester compound 4a the three different methylene protons of the
newly synthesized esters were detected to appear as three sepa-
rate singlets at 4.65, 4.75 and 5.51 ppm as expected for ester
compounds. The seven aromatic protons of the ester com-
pound 4a appear as four doublets, two singlets and a triplet.
These doublets appear at chemical shift values of 7.12–
7.21 ppm corresponding to H4 and H13, and 7.27–7.68 ppm
for H5 and H15. Two singlets are observed within the 7.10–
7.83 ppm region of spectrum, which corresponds to H7 and
a) R1=H, R2=CH3,Y=OH(m)                    
b) R1=CH3, R2=H,Y=OH(o)
c) R1=H, R2=CH3,Y=CH3(p)
d) R1=R2=H,Y=OH(o)
e) R1=H, R2=CH3,Y=OMe(p)
4a) R1=H, R2=CH3, Y=O(CO)CH2Cl (m)
4b)  R1=CH3, R2=H, Y=O(CO)CH2Cl (o)
4c)  R1=H, R2=CH3,Y=CH3(p)
4d)  R1=R2=H, Y=O(CO)CH2Cl (o)
4e)  R1=H, R2=CH3,Y=OMe(p)
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In the 1H NMR spectra of the amide compound 4c the two dif-
ferent methylene protons appear as two separate singlets at 4.75
and 5.55 ppm. Aromatic protons of compound 4c show similar
characteristics as those discussed in compound 4a. In the 13C
NMR spectrum of 4c, peak at 167.72 corresponds to carbonyl
carbon and peaks at 21.10, 21.50, 43.96 and 50.16 indicate the
presence of methyl and methylene carbons, respectively, in the
structure. The EI-MS of 4b registered a molecular ion peak at
(m/z 424, 10%) (M++1) and fragment ions at (m/z 347,
60.9%), (m/z 105, 3.9%) and the base peak at (m/z 241,
100%) well attests our assignment. The mass spectrum of 4c
showed a molecular ion peak at (m/z 346.1, 15%) (M++1).
The base peak observed at m/z 345.1 and other fragmentations
conﬁrmed our assignment. Along with the above spectral meth-
ods, the interesting mass fragmentation study has also helped to
conﬁrm the structure of the compounds 2a–4e.
As a result we can conclude that the suggested formulae
were conﬁrmed by spectroscopy.4. Conclusion
Unlike other studies in the literature (Vicini et al., 2003;
Billman and Diesing, 1957; Davion et al., 2004), the com-
pounds of 2a and 4e were synthesized according to the refer-
ences given but by realising some modiﬁcations such as in
reaction time, solvent type and atmospheric pressure a de-
crease in reaction time was obtained and an increase in reac-
tion yield. Additionally the solvent used is not greately
hazardous for the environment and this also means an impor-
tant beneﬁt of our method. All spectroscopic analyses con-
ﬁrmed the proposed structures of these compounds.Acknowledgements
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